Logo image of CSIQ

CANADIAN SOLAR INC (CSIQ) Stock Fundamental Analysis

USA - NASDAQ:CSIQ - CA1366351098 - Common Stock

12.37 USD
+0.16 (+1.31%)
Last: 9/17/2025, 12:36:48 PM
Fundamental Rating

2

CSIQ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 112 industry peers in the Semiconductors & Semiconductor Equipment industry. CSIQ may be in some trouble as it scores bad on both profitability and health. CSIQ has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CSIQ has reported negative net income.
CSIQ had a negative operating cash flow in the past year.
In the past 5 years CSIQ has always been profitable.
In multiple years CSIQ reported negative operating cash flow during the last 5 years.
CSIQ Yearly Net Income VS EBIT VS OCF VS FCFCSIQ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

CSIQ has a Return On Assets (-0.05%) which is in line with its industry peers.
CSIQ has a Return On Equity (-0.24%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.05%
ROE -0.24%
ROIC N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
CSIQ Yearly ROA, ROE, ROICCSIQ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

CSIQ's Profit Margin has declined in the last couple of years.
CSIQ has a worse Gross Margin (18.75%) than 82.14% of its industry peers.
CSIQ's Gross Margin has declined in the last couple of years.
CSIQ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
CSIQ Yearly Profit, Operating, Gross MarginsCSIQ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

0

2. Health

2.1 Basic Checks

CSIQ does not have a ROIC to compare to the WACC, probably because it is not profitable.
CSIQ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for CSIQ has been increased compared to 5 years ago.
CSIQ has a worse debt/assets ratio than last year.
CSIQ Yearly Shares OutstandingCSIQ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CSIQ Yearly Total Debt VS Total AssetsCSIQ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

CSIQ has an Altman-Z score of 0.62. This is a bad value and indicates that CSIQ is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.62, CSIQ is doing worse than 72.32% of the companies in the same industry.
A Debt/Equity ratio of 1.58 is on the high side and indicates that CSIQ has dependencies on debt financing.
The Debt to Equity ratio of CSIQ (1.58) is worse than 91.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.58
Debt/FCF N/A
Altman-Z 0.62
ROIC/WACCN/A
WACC3.94%
CSIQ Yearly LT Debt VS Equity VS FCFCSIQ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B -2B 3B

2.3 Liquidity

CSIQ has a Current Ratio of 1.09. This is a normal value and indicates that CSIQ is financially healthy and should not expect problems in meeting its short term obligations.
CSIQ has a worse Current ratio (1.09) than 90.18% of its industry peers.
A Quick Ratio of 0.87 indicates that CSIQ may have some problems paying its short term obligations.
CSIQ has a worse Quick ratio (0.87) than 89.29% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 0.87
CSIQ Yearly Current Assets VS Current LiabilitesCSIQ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

5

3. Growth

3.1 Past

The earnings per share for CSIQ have decreased strongly by -624.07% in the last year.
CSIQ shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -28.29% yearly.
The Revenue has decreased by -9.11% in the past year.
The Revenue has been growing by 13.37% on average over the past years. This is quite good.
EPS 1Y (TTM)-624.07%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%-260%
Revenue 1Y (TTM)-9.11%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%3.57%

3.2 Future

CSIQ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 52.21% yearly.
The Revenue is expected to grow by 8.99% on average over the next years. This is quite good.
EPS Next Y107.79%
EPS Next 2Y73.18%
EPS Next 3Y55.63%
EPS Next 5Y52.21%
Revenue Next Year-5.35%
Revenue Next 2Y8.42%
Revenue Next 3Y9.51%
Revenue Next 5Y8.99%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CSIQ Yearly Revenue VS EstimatesCSIQ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B 10B
CSIQ Yearly EPS VS EstimatesCSIQ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4 6 8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

CSIQ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 8.60, the valuation of CSIQ can be described as reasonable.
100.00% of the companies in the same industry are more expensive than CSIQ, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.71. CSIQ is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 8.6
CSIQ Price Earnings VS Forward Price EarningsCSIQ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CSIQ indicates a rather cheap valuation: CSIQ is cheaper than 88.39% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.47
CSIQ Per share dataCSIQ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CSIQ's earnings are expected to grow with 55.63% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y73.18%
EPS Next 3Y55.63%

More info and screens

0

5. Dividend

5.1 Amount

CSIQ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CANADIAN SOLAR INC

NASDAQ:CSIQ (9/17/2025, 12:36:48 PM)

12.37

+0.16 (+1.31%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-21 2025-08-21/bmo
Earnings (Next)10-27 2025-10-27
Inst Owners48.64%
Inst Owner Change-18.77%
Ins Owners21.18%
Ins Owner ChangeN/A
Market Cap828.42M
Analysts71.76
Price Target12.85 (3.88%)
Short Float %13.41%
Short Ratio4.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-50.11%
Min EPS beat(2)-104.86%
Max EPS beat(2)4.63%
EPS beat(4)1
Avg EPS beat(4)-378.47%
Min EPS beat(4)-1389.64%
Max EPS beat(4)4.63%
EPS beat(8)2
Avg EPS beat(8)-54.25%
EPS beat(12)6
Avg EPS beat(12)-10.08%
EPS beat(16)9
Avg EPS beat(16)16.21%
Revenue beat(2)1
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-14.75%
Max Revenue beat(2)7.03%
Revenue beat(4)1
Avg Revenue beat(4)-6.62%
Min Revenue beat(4)-14.75%
Max Revenue beat(4)7.03%
Revenue beat(8)3
Avg Revenue beat(8)-4.52%
Revenue beat(12)4
Avg Revenue beat(12)-4.43%
Revenue beat(16)5
Avg Revenue beat(16)-4.57%
PT rev (1m)-6.67%
PT rev (3m)-4.7%
EPS NQ rev (1m)-12.59%
EPS NQ rev (3m)-217.18%
EPS NY rev (1m)0%
EPS NY rev (3m)143.54%
Revenue NQ rev (1m)-13.46%
Revenue NQ rev (3m)-27.05%
Revenue NY rev (1m)-8.28%
Revenue NY rev (3m)-7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.6
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B 0.29
P/tB 0.29
EV/EBITDA 11.47
EPS(TTM)-2.83
EYN/A
EPS(NY)1.44
Fwd EY11.63%
FCF(TTM)-30.57
FCFYN/A
OCF(TTM)-3.59
OCFYN/A
SpS88.39
BVpS42.63
TBVpS42.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.05%
ROE -0.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.75%
FCFM N/A
ROA(3y)1.74%
ROA(5y)1.75%
ROE(3y)8.12%
ROE(5y)7.8%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-30.67%
PM growth 5Y-35.43%
GM growth 3Y-1.09%
GM growth 5Y-5.77%
F-Score2
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity 1.58
Debt/FCF N/A
Debt/EBITDA 10.07
Cap/Depr 360.35%
Cap/Sales 30.53%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 0.87
Altman-Z 0.62
F-Score2
WACC3.94%
ROIC/WACCN/A
Cap/Depr(3y)379.19%
Cap/Depr(5y)289.93%
Cap/Sales(3y)19.88%
Cap/Sales(5y)15.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-624.07%
EPS 3Y-26.92%
EPS 5Y-28.29%
EPS Q2Q%-260%
EPS Next Y107.79%
EPS Next 2Y73.18%
EPS Next 3Y55.63%
EPS Next 5Y52.21%
Revenue 1Y (TTM)-9.11%
Revenue growth 3Y4.33%
Revenue growth 5Y13.37%
Sales Q2Q%3.57%
Revenue Next Year-5.35%
Revenue Next 2Y8.42%
Revenue Next 3Y9.51%
Revenue Next 5Y8.99%
EBIT growth 1Y-130.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year368.17%
EBIT Next 3Y107.42%
EBIT Next 5Y67.37%
FCF growth 1Y-227.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-229.32%
OCF growth 3YN/A
OCF growth 5YN/A